BioHealth News Archive
MedImmune and UCFS Announce Seven-Project Partnership – GEN News
In a partnership announced today, MedImmune, AstraZeneca’s global biologics and development arm, and the University of California, San Francisco will initiate further exploration of…
Read More
Qiagen Inks Master CDx Collaboration With Array BioPharma | GenomeWeb
NEW YORK (GenomeWeb) – Qiagen said yesterday that it has inked a master collaboration for companion diagnostics codevelopment with Array BioPharma, the 15th pharma…
Read More
HHS Idea Lab launches initiative to help consumers participate in medical device development – MedCity NewsMedCity News
The way Health and Human Services Chief Technology Officer Susannah Fox sees it, the U.S. government totally missed the Internet boom and has been…
Read More
Advanced Accelerator Applications (AAAP) Enters Exclusive Deal With Johns Hopkins University for Prostate Cancer
Advanced Accelerator Applications S.A. (NASDAQ: AAAP) announced an exclusive license agreement with Johns Hopkins University in Baltimore, Maryland to develop and market PSMA-SR6, a…
Read More
AstraZeneca and Moderna Therapeutics Announce New Collaboration to Co-Develop and Co-Commercialize Immuno-Oncology mRNA Therapeutics™ | Business Wire
AstraZeneca, along with its global biologics research and development arm, MedImmune, and Moderna Therapeutics today announced a new collaboration to discover, co-develop and co-commercialize…
Read More
Dreamit Partners With Independence Blue Cross And Penn Medicine To Launch Revamped Dreamit..
Leading global start up accelerator Dreamit today announced that it has renewed its partnerships with industry leaders Independence Blue Cross (Independence) and Penn Medicine…
Read More
Why NIH Wants to Change Incentives for Researchers – Nextgov.com
Biological researchers should be able to share datasets the same way they share published scientific articles — at least, that’s what the National Institutes…
Read More
‘Renaissance’ ideas – Piero Formica – LinkedIn
Rewards for creative people; investments in new ideas that challenge the power of the Pope and sovereign rulers, that give impetus to science and…
Read More
AMA invests $15 million to launch Silicon Valley innovation hub Health2047 | Healthcare IT News
The American Medical Association has invested $15 million to become founding partner of Health2047, a high-tech incubator that will explore innovative solutions to some of the…
Read More
Rockville-based Sucampo Pharmaceuticals Inc. acquires exclusive option for colon cancer prevention drug in deal worth up to $190 million – Washington Business Journal
Sucampo Pharmaceuticals (NASDAQ:SCMP) has acquired an option to commercialize a drug candidate aimed at preventing colon cancer among a high-risk group of patients in…
Read More
NEXT WEEK! Join BioBuzz & JHU in Gaithersburg on 1/21
Thursday January 21, 2016 from 5:00 PM to 7:00 PM EST Johns Hopkins Montgomery County Campus is also a site for the popular Osher…
Read More
Sucampo Pharma (SCMP) Enters Option Agreement to License CPP-1X/Sulindac Product in North America
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq: SCMP) announced an option and collaboration agreement under which Cancer Prevention Pharmaceuticals, Inc. (CPP) has granted Sucampo the sole…
Read More
The definitive guide to the J.P. Morgan Healthcare Conference – MedCity News
Ah. Another January, another J.P. Morgan Healthcare Conference — where this year’s biggest biopharma deals are just a cocktail and a handshake away. As…
Read More
Biopharma’s top brass forms new immunotherapy coalition – MedCity News
We’re one step closer to open-source collaboration in the life sciences – and could come a hell of a lot closer to completely revolutionizing…
Read More
Emergent BioSolutions Receives Favorable IRS Private Letter Ruling in Connection With its Planned Biosciences Business Spin-Off – NASDAQ.com
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has received a favorable private letter ruling from the Internal Revenue Service related to the planned…
Read More